Role of Protein Tyrosine Phosphatases in the Modulation of Insulin Signaling and Their Implication in the Pathogenesis of Obesity-linked Insulin Resistance

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2013 Nov 23

PMID 24264858

Citations 35

Authors

Elaine Xu

Michael Schwab

Andre Marette

Affiliations

Soon will be listed here.

Abstract

Insulin resistance is a major disorder that links obesity to type 2 diabetes mellitus (T2D). It involves defects in the insulin actions owing to a reduced ability of insulin to trigger key signaling pathways in major metabolic tissues. The pathogenesis of insulin resistance involves several inhibitory molecules that interfere with the tyrosine phosphorylation of the insulin receptor and its downstream effectors. Among those, growing interest has been developed toward the protein tyrosine phosphatases (PTPs), a large family of enzymes that can inactivate crucial signaling effectors in the insulin signaling cascade by dephosphorylating their tyrosine residues. Herein we briefly review the role of several PTPs that have been shown to be implicated in the regulation of insulin action, and then focus on the Src homology 2 (SH2) domain-containing SHP1 and SHP2 enzymes, since recent reports have indicated major roles for these PTPs in the control of insulin action and glucose metabolism. Finally, the therapeutic potential of targeting PTPs for combating insulin resistance and alleviating T2D will be discussed.

Citing Articles

TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.

Ming S, Li X, Xiao Q, Qu S, Wang Q, Fang Q J Clin Invest. 2024; 135(1).

PMID: 39405126 PMC: 11684808. DOI: 10.1172/JCI159400.

Metabolites of traditional Chinese medicine targeting PI3K/AKT signaling pathway for hypoglycemic effect in type 2 diabetes.

Feng Y, Ren Y, Zhang X, Yang S, Jiao Q, Li Q Front Pharmacol. 2024; 15:1373711.

PMID: 38799166 PMC: 11116707. DOI: 10.3389/fphar.2024.1373711.

Burdock miR8175 in diet improves insulin resistance induced by obesity in mice through food absorption.

Song H, Shi H, Ji M, Ding J, Cong L, Chen S iScience. 2024; 27(5):109705.

PMID: 38660399 PMC: 11039404. DOI: 10.1016/j.isci.2024.109705.

Vanadium Complexes with Thioanilide Derivatives of Amino Acids: Inhibition of Human Phosphatases and Specificity in Various Cell Models of Metabolic Disturbances.

Kazek G, Gluch-Lutwin M, Mordyl B, Menaszek E, Kubacka M, Jurowska A Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399444 PMC: 10892041. DOI: 10.3390/ph17020229.

How Can Insulin Resistance Cause Alzheimer's Disease?.

Yoon J, Hwang J, Son S, Choi J, You S, Park H Int J Mol Sci. 2023; 24(4).

PMID: 36834911 PMC: 9966425. DOI: 10.3390/ijms24043506.

References

Zhang S, Liu S, Tao R, Wei D, Chen L, Shen W . A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes. J Am Chem Soc. 2012; 134(43):18116-24. PMC: 3505080. DOI: 10.1021/ja308212y. View

Wang W, Huang L, Huang Y, Yin J, Berk A, Friedman J . Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev Cell. 2009; 16(5):764-71. PMC: 2835773. DOI: 10.1016/j.devcel.2009.04.006. View

Goossens G . The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2007; 94(2):206-18. DOI: 10.1016/j.physbeh.2007.10.010. View

Yoshii H, Lam T, Gupta N, Goh T, Haber C, Uchino H . Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux. Am J Physiol Endocrinol Metab. 2006; 290(6):E1089-97. DOI: 10.1152/ajpendo.00306.2005. View

Ozawa T, Nakata K, Mizuno K, Yakura H . Negative autoregulation of Src homology region 2-domain-containing phosphatase-1 in rat basophilic leukemia-2H3 cells. Int Immunol. 2007; 19(9):1049-61. DOI: 10.1093/intimm/dxm070. View

Agouni A, Mody N, Owen C, Czopek A, Zimmer D, Bentires-Alj M . Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress. Biochem J. 2011; 438(2):369-78. PMC: 3744093. DOI: 10.1042/BJ20110373. View

Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J . Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta. 2006; 1760(10):1505-12. DOI: 10.1016/j.bbagen.2006.05.009. View

Yu Z, Su L, Hoglinger O, Jaramillo M, Banville D, Shen S . SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1998; 273(6):3687-94. DOI: 10.1074/jbc.273.6.3687. View

Jin Y, Yu C, Burakoff S . Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity. J Biol Chem. 1999; 274(40):28301-7. DOI: 10.1074/jbc.274.40.28301. View

10.

Le H, Ponniah S, Pallen C . Insulin signaling and glucose homeostasis in mice lacking protein tyrosine phosphatase alpha. Biochem Biophys Res Commun. 2004; 314(2):321-9. DOI: 10.1016/j.bbrc.2003.12.087. View

11.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

12.

Lorenzen J, Dadabay C, FISCHER E . COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Biol. 1995; 131(3):631-43. PMC: 2120615. DOI: 10.1083/jcb.131.3.631. View

13.

Yang J, Liang X, Niu T, Meng W, Zhao Z, Zhou G . Crystal structure of the catalytic domain of protein-tyrosine phosphatase SHP-1. J Biol Chem. 1998; 273(43):28199-207. DOI: 10.1074/jbc.273.43.28199. View

14.

Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A . Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology. 2004; 146(3):1328-37. DOI: 10.1210/en.2004-0777. View

15.

Kovacina K, Roth R . Characterization of the endogenous insulin receptor-related receptor in neuroblastomas. J Biol Chem. 1995; 270(4):1881-7. DOI: 10.1074/jbc.270.4.1881. View

16.

Tremblay F, Marette A . Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem. 2001; 276(41):38052-60. DOI: 10.1074/jbc.M106703200. View

17.

OSullivan J, MAHAN C . Blood sugar levels, glycosuria, and body weight related to development of diabetes mellitus. The Oxford epidemiologic study 17 years later. JAMA. 1965; 194(6):587-92. View

18.

Patti M, Kahn C . The insulin receptor--a critical link in glucose homeostasis and insulin action. J Basic Clin Physiol Pharmacol. 1999; 9(2-4):89-109. DOI: 10.1515/jbcpp.1998.9.2-4.89. View

19.

Koyama K, Chen G, Lee Y, Unger R . Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol. 1997; 273(4):E708-13. DOI: 10.1152/ajpendo.1997.273.4.E708. View

20.

Maegawa H, Kashiwagi A, Fujita T, Ugi S, Hasegawa M, Obata T . SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates. Biochem Biophys Res Commun. 1996; 228(1):122-7. DOI: 10.1006/bbrc.1996.1626. View